Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Elliot is calling on the company to replace CEO Bob Jordan, revise its board of directors, and conduct a comprehensive business review.
The EU has a 10% tariff on EVs imported from China, but it could soon increase to 25% or 30%.
The diamond industry is undergoing a major shake-up. But can just how far can the bottom fall for the industry?
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The world’s largest fast food chain lost its “Big Mac” trademark for chicken sandwiches following a European Union court ruling.
The plaintiffs argue the league made an anti-competitive agreement forcing fans to pay for out-of-market broadcasts in one package.
Last year saw the highest private in-patient admissions since records began, totaling roughly 900,000, a 7% increase from 2022.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The industry just boosted its profit forecast for 2024 but warns that return on invested capital hurts the chance for sustainable profits.
One market research firm said even duties in the range of 15%-30% won’t keep most of the country’s carmakers out of Europe.
The brewer is reportedly in early talks to sell to Japan’s Suntory, which owns American spirits brands Jim Beam and Maker’s Mark.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.